# Thiamine Supplementation in High Risk Cardiac Surgery Patients

> **NCT03306732** · PHASE4 · COMPLETED · sponsor: **Meshalkin Research Institute of Pathology of Circulation** · enrollment: 40 (actual)

## Conditions studied

- Cardiac Surgery

## Interventions

- **DRUG:** Thiamine hydrochloride (200mg) dissolved in 100 ml of normal saline
- **DRUG:** Normal saline (100ml)

## Key facts

- **NCT ID:** NCT03306732
- **Lead sponsor:** Meshalkin Research Institute of Pathology of Circulation
- **Sponsor class:** NETWORK
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-10-19
- **Primary completion:** 2018-05-18
- **Final completion:** 2018-06-18
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2018-06-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03306732

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03306732, "Thiamine Supplementation in High Risk Cardiac Surgery Patients". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT03306732. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*